Hydrogen sulphide inhibits cardiomyocyte hypertrophy by up-regulating miR-133a

Biochemical and Biophysical Research Communications

Volumn 413, Issue 2, 2011, Pages 342-347

  Liu, Jun ^a   Hao, Dan Dan ^a   Zhang, Jin Sheng ^a   Zhu, Yi Chun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cardiomyocyte hypertrophy; Hydrogen sulphide; MicroRNA 133a; Reactive oxygen species

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HYDROGEN SULFIDE; LEUCINE; MESSENGER RNA; MICRORNA; MICRORNA 133A; MICRORNA 21; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; UPREGULATION;

ANIMALS; CARDIOMEGALY; CELL LINE; HYDROGEN SULFIDE; HYPERTROPHY; MICRORNAS; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; RATS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SULFIDES; UP-REGULATION;

EID: 80053113925     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.101     Document Type: Article

References (26)

1. Geng B., Yang J., Qi Y., Zhao J., Pang Y., Du J., Tang C. H2S generated by heart in rat and its effects on cardiac function. Biochem. Biophys. Res. Commun. 2004, 313:362-368.
2. Bian J.S., Yong Q.C., Pan T.T., Feng Z.N., Ali M.Y., Zhou S., Moore P.K. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J. Pharmacol. Exp. Ther. 2006, 316:670-678.
3. 2S) protects against regional myocardial ischemia-reperfusion injury-evidence for a role of K ATP channels. Basic. Res. Cardiol. 2006, 101:53-60.
4. Shi Y.X., Chen Y., Zhu Y.Z., Huang G.Y., Moore P.K., Huang S.H., et al. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2093-H2100.
5. Huang H., Tang Q.Z., Wang A.B., Chen M., Yan L., Liu C., et al. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-activated kinase 1-dependent signaling. Hypertension 2010, 56:232-239.
6. Li H.L., She Z.G., Li T.B., Wang A.B., Yang Q., Wei Y.S., et al. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice. Hypertension 2007, 49:1399-1408.
7. Ikeda S., He A., Kong S.W., Lu J., Bejar R., Bodyak N., et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol. Cell. Biol. 2009, 29:2193-2204.
8. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13:613-618.
9. Wu F., Yang Z., Li G. Role of specific microRNAs for endothelial function and angiogenesis. Biochem. Biophys. Res. Commun. 2009, 386:549-553.
10. Cheng Y., Liu X., Yang J., Lin Y., Xu D.Z., Lu Q., et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 2009, 105:158-166.
11. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., et al. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
12. Maes O.C., Sarojini H., Wang E. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J. Cell. Physiol. 2009, 221:109-119.
13. Ren X.P., Wu J., Wang X., Sartor M.A., Qian J., Jones K., et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009, 119:2357-2366.
14. Pimentel D.R., Adachi T., Ido Y., Heibeck T., Jiang B., Lee Y., et al. Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J. Mol. Cell Cardiol. 2006, 41:613-622.
15. Simpson P., Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ. Res. 1982, 50:101-116.
16. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001, 25:386-401.
17. Hirotani S., Otsu K., Nishida K., Higuchi Y., Morita T., Nakayama H., et al. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 2002, 105:509-515.
18. Frank D., Kuhn C., van Eickels M., Gehring D., Hanselmann C., Lippl S. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy. Circulation 2007, 116:2587-2596.
19. Bush E.W., Hood D.B., Papst P.J., Chapo J.A., Minobe W., Bristow M.R., et al. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J. Biol. Chem. 2006, 281:33487-33496.
20. Zou M.X., Roy A.A., Zhao Q., Kirshenbaum L.A., Karmazyn M., Chidiac P. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes. Cell. Signal. 2006, 18:1655-1663.
21. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 2000, 35:19-24.
22. Hayashi D., Kudoh S., Shiojima I., Zou Y., Harada K., Shimoyama M., et al. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1. Biochem. Biophys. Res. Commun. 2004, 322:310-319.
23. Cheng Y., Ji R., Yue J., Yang J., Liu X., Chen H., Dean D.B., et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am. J. Pathol. 2007, 170:1831-1840.
24. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 2006, 103:18255-18260.
25. Luo J.D., Xie F., Zhang W.W., Ma X.D., Guan J.X., Chen X. Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes. Br. J. Pharmacol. 2001, 132:159-164.
26. Nakamura K., Fushimi K., Kouchi H., Mihara K., Miyazaki M., Ohe T., et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor- and angiotensin II. Circulation 1998, 98:794-799.